Cardiac screening before returning to elite sport after SARS-CoV-2 infection

Arch Cardiovasc Dis. 2022 Nov;115(11):562-570. doi: 10.1016/j.acvd.2022.06.005. Epub 2022 Sep 29.


Background: SARS-CoV-2 infection can induce cardiac damage. Therefore, in the absence of clear data, a cardiac evaluation was recommended for athletes before returning to play after recent SARS-CoV-2 infection.

Aim: To assess the proportion of anomalies detected by this cardiac screening.

Methods: We reviewed the medical files of elite athletes referred for cardiac evaluation before returning to play after a non-hospitalized SARS-CoV-2 infection (based on a positive polymerase chain reaction or antigen test) from March 2020 to July 2021 in 12 French centres.

Results: A total of 554 elite athletes (professional or national level) were included (median age 22 years, 72.0% male). An electrocardiogram (ECG), echocardiogram and exercise test were performed in 551 (99.5%), 497 (89.7%) and 293 (52.9%) athletes, respectively. We found anomalies with a potential link with SARS-CoV-2 infection in four ECGs (0.7%), three echocardiograms (0.6%) and three exercise tests (1.0%). Cardiac magnetic resonance imaging was performed in 34 athletes (6.1%), mostly due to abnormal first-line examinations, and was abnormal in one (2.9%). The rates of those abnormalities were not higher among athletes with cardiac symptoms or more severe forms of non-hospitalized SARS-CoV-2 infection. Only one athlete had a possible SARS-CoV-2 myocarditis and sport was temporally contraindicated. None had a major cardiac event declared during the follow-up.

Conclusion: The proportion of cardiac involvement after non-hospitalized forms of SARS-CoV-2 infection in athletes are very low. Systematic cardiac screening before returning to play seems to be unnecessary.

Keywords: Athletes; Myocarditis; Return-to-play; SARS-CoV-2; Screening.

Publication types

  • Review

MeSH terms

  • Adult
  • Athletes
  • COVID-19* / diagnosis
  • COVID-19* / epidemiology
  • Female
  • Heart
  • Humans
  • Male
  • Myocarditis*
  • SARS-CoV-2
  • Young Adult